OBJECTIVES: To review the definitions of treatment-resistant mania (TRM) in the literature and propose criteria for an operationalized definition. METHODS: A systematic search of five databases (MEDLINE, EMBASE, PsychInfo, Cochrane Central, and CINAHL) and data extraction of eligible articles. RESULTS: In total, 47 articles addressing the concept of TRM were included, comprising 16 case reports, 11 case series, 3 randomized clinical trials, 8 open-label clinical trials, 1 experimental study, 7 narrative reviews, and 1 systematic review. While reviews discussed several challenges in defining TRM, definitions varied substantially based on different criteria for severity of mania, duration of mania, and use of specific therapeutic agents with minimal dosages and duration of treatment. Only a handful of the reviewed articles operationalized these criteria. CONCLUSION: While the concept of TRM has been discussed in the literature for over three decades, we could not find an agreed-upon operationalized definition based on specific criteria. We propose and discuss a possible definition that could be used by clinicians to guide their practice and by researchers to assess the prevalence of TRM and develop and test interventions targeting TRM.

Campbell Family Mental Health Research Institute Centre for Addiction and Mental Health Toronto Ontario Canada

Department of Psychiatry Dalhousie University Halifax Nova Scotia Canada

Department of Psychiatry Temerty Faculty of Medicine University of Toronto Toronto Ontario Canada

Department of Psychiatry Weil Cornell Medicine New York New York USA

National Institute of Mental Health Klecany Czech Republic

Zobrazit více v PubMed

Vieta E, Berk M, Schulze T, et al. Bipolar Disorders. Nat Rev Dis Primers. 2018;4:16. PubMed

Carvalho A, Firth J, Vieta E. Bipolar Disorder. NEJM. 2020;383(1):58–66. PubMed

Grande I, Berk M, Birmaher B, Vieta E. Bipolar Disorder. The Lancet. 2016;9(387):1561–1572. PubMed

Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty JP. The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. Postgraduate medicine. 2000;Spec No:1-104. PubMed

Hirschfield RB CL, Gitlin M, Keck P, et al. Practice Guideline For The Treatment of Patients With Bipolar Disorder. Second Edition. In: American Psychiatric Association; 2002.

Tohen M, Frank E, Bowden C, et al. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord. 2009;11(5):453–473. PubMed

Fountoulakis Yatham, Grunze, et al. The International College of Neuro- Psychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 2: Review, grading of the evidence, and a precise algorithm. International Journal of Neuropsychopharmacology. Int J Neuropsychopharmacol. 2016. PubMed PMC

Goodwin Haddad, Ferrier, et al. Evidence-based guidelines for treating bipolar disorder: revised third edition Recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2016;30(6):495–553. PubMed PMC

Yatham L, Kennedy S, Parikh S, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20:97–170. PubMed PMC

Fountoulakis KN, Yatham LN, Grunze H, et al. The CINP guidelines on the definition and evidence-based interventions for treatment-resistant bipolar disorder. International Journal of Neuropsychopharmacology. 2020;23(4):230–256. PubMed PMC

Sackeim H The definition and meaning of treatment-resistant depression. J Clin Psychiatry. 2001;62:10–17. PubMed

Sachs G Treatment-resistant bipolar depression. Psychiatr Clin North Am. 1996;19(2):215–236. PubMed

Burt T, Sachs G, Demopulos C. Donepezil in Treatment-Resistant Bipolar Disorder Biol Psychiatry. 1999;45(8):959–964. PubMed

Schaffer AL AJ; Joffe RT. Mexiletene in treatment-resistant bipolar disorder. J Affect Disord. 2000;57(1–3):249–253. PubMed

Gitlin M Treatment-resistant bipolar disorder. Mol Psychiatry. 2006;11(3):227–240. PubMed

Poon SS K; Baldessarini RJ. Pharmacological Approaches for Treatment-resistant Bipolar Disorder. Curr Neuropharmacol. 2015;13(5):592–604. PubMed PMC

Macedo-Soares MB, Moreno RA, Rigonatti SP, Lafer B. Efficacy of electroconvulsive therapy in treatment-resistant bipolar disorder: a case series. J ect. 2005;21(1):31–34. PubMed

Judd L, Akiskal H, Schettler P, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of Bipolar II Disorder. Arch Gen Psychiatry. 2003;60(3):261–269. PubMed

Judd L, Akiskal H, Schettler P, et al. The long-term natural history of the weekly symptomatic status of Bipolar I Disorder. Arch Gen Psychiatry. 2002;59(6):530–537. PubMed

Lally J, McDonald C. Refractory mania and inability to consent: an important role for involuntary ECT. Ir J Psychol Med. 2013;30(1):73–76. PubMed

Ramsey C, Spira A, Mojtabai R, Eaton W, Roth K, Hochang B. Lifetime Manic Spectrum Episodes and All-Cause Mortality: 26-Year Follow-Up of the NIMH Epidemiologic Catchment Area Study. J Affect Disord. 2013;151(1):337–342. PubMed PMC

Yatham L Atypical antipsychotics for bipolar disorder. Psychiatr Clin North Am. 2005;28:325–347. PubMed

Ketter T Combination therapy versys monotherapy in bipolar disorder. J Clin Psychiatry. 2008;69(12). PubMed

Liberati LA DG; Tetzlaff J, Murlow C; Gøtzsche PG; Ioannidis JPA; Clarke M; Devereaux PJ; Klejnen J; Moher D The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339(b2700). PubMed PMC

Mahmood T, Devlin M, Silverstone T. Clozapine in the management of bipolar and schizoaffective manic episodes resistant to standard treatment. Australian and New Zealand Journal of Psychiatry. 1997;31(3):424–426. PubMed

Chanpattana W Combined ECT and clozapine in treatment-resistant mania. The Journal of ECT. 2000;16(2):204–207. PubMed

Dunayevich E, Strakowski SM. Quetiapine for treatment-resistant mania. American Journal of Psychiatry. 2000;157(8):1341–1341. PubMed

Malhi GS, Mitchell PB, Parker GB. Rediscovering chronic mania. Acta psychiatrica Scandinavica. 2001;104(2):153–156. PubMed

Tsao Jain, Gibson Guedet, Lehrmann. Maintenance ECT for Recurrent Medication-refractory Mania. The Journal of ECT. 2004;20(2):118–119. PubMed

Chen C-K, Shiah IS, Yeh C-B, Mao W-C, Chang C-C. Combination Treatment of Clozapine and Topiramate in Resistant Rapid-Cycling Bipolar Disorder. Clinical Neuropharmacology. 2005;28(3):136–138. PubMed

Nascimento AL, Appolinario JC, Segenreich D, Cavalcanti MT, Brasil MAA. Maintenance electroconvulsive therapy for recurrent refractory mania. Bipolar disorders. 2006;8(3):301–303. PubMed

Huang M-C, Wang Y-B, Chan C-H. Estrogen-progesterone combination for treatment-refractory post-partum mania. Psychiatry Clin Neurosci. 2008;62(1):126. PubMed

Robinson LA, Penzner JB, Arkow S, Kahn DA, Berman JA. Electroconvulsive therapy for the treatment of refractory mania. Journal of Psychiatric Practice®. 2011;17(1):61–66. PubMed

Kohli S, Singh V. Use of asenapine in a case of treatment-resistant bipolar disorder. Progress in Neurology & Psychiatry. 2013;17(6):7–8.

Eloff I, Esterhuysen W. Reserpine for the treatment of refractory mania. A Afr J Psych. 2014;20(1):31–32.

Muneer A Prolonged mania in a case of bipolar affective disorder. Journal of the Pakistan Medical Association. 2014;64(10):1198–1200. PubMed

Keat TC, Chew PY, Rahaiza E, Pinn CS, Kaur B. Treatment resistant mania: A case report. ASEAN Journal of Psychiatry. 2016;17(1):120–123.

Modak T, Kumar S, Pal A, Gupta R, Pattanayak RD, Khandelwal SK. Chlorpromazine as Prophylaxis for Bipolar Disorder with Treatment- and Electroconvulsive Therapy-Refractory Mania: Old Horse, New Trick. Indian journal of psychological medicine. 2017;39(4):539–541. PubMed PMC

Enokida T, Noda T, Usami T, Satake N, Nakagome K. Electroconvulsive Therapy on Treatment-resistant Mania in Bipolar Disorder with No Concurrent Antipsychotics: A Case Report. Clinical Psychopharmacology and Neuroscience. 2022;20(1):190–193. PubMed PMC

Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry. 1978;133:429–435. PubMed

Antonacci DJ, Swartz CM. Clozapine treatment of euphoric mania. Annals of Clinical Psychiatry. 1995;7(4):203–206. PubMed

Goodnick PJ. Risperidone treatment of refractory acute mania Journal of Clinical Psychiatry. 1995;56(7 SUPPL.):431–432. PubMed

Zarate C, Tohen M, Banov M, Weiss M, Cole J. Is clozapine a mood stabilizer? J Clin Psychiatry. 1995;56(3):108–112. PubMed

Poyurovsky M, Weizman A. Safety and effectiveness of combined ECT and clozapine in treatment-resistant mania. European Psychiatry. 1996;11(6):319–321. PubMed

Bd Macedo-Soares, Moreno R, Rigonatti S, Lafer B. Efficacy of Electroconvulsive Therapy in Treatment-Resistant Bipolar Disorder: A Case Series. J ECT. 2005;21(1):31–34. PubMed

Ifteni P, Correll C, Nielsen J, Burtea V, Kane J, Manu P. Rapid clozapine titration in treatment-refractory bipolar disorder. J Affect Disord. 2014;166:168–172. PubMed

Aksoy Poyraz C, Turan S, Demirel OF, Usta Saglam NG, Yildiz N, Duran A. Effectiveness of ultra-rapid dose titration of clozapine for treatment-resistant bipolar mania: case series. Therapeutic advances in psychopharmacology. 2015;5(4):237–242. PubMed PMC

Benzoni O, Fazzari G, Marangoni C, Placentino A, Rossi A. Treatment of resistant mood and schizoaffective disorders with electroconvulsive therapy: A case series of 264 patients. Journal of Psychopathology. 2015;21(3):266–268.

Kumar SR, Sinha VK, Tikka SK, Goyal N. Gamma activity model for treatment-resistant bipolar psychotic mania. Indian Journal of Pharmacology. 2015;47(2):215–218. PubMed PMC

Van Riel WG, Vieta E, Martinez-Aran A, et al. Chronic mania revisited: factors associated with treatment non-response during prospective follow-up of a large European cohort (EMBLEM). World J Biol Psychiatry. 2008;9(4):313–320. PubMed

Kramlinger K, Post R. Verapamil in Treatment-Resistant Mania: An Open Trial. Acta Psychiatr Scand 1989;79(4). PubMed

Baumgartner A, Bauer M, Hellweg R. Treatment of intractable non-rapid cycling bipolar affective disorder with high-dose thyroxine: An open clinical trial. Neuropsychopharmacology. 1994;10(3):183–189. PubMed

Calabrese J, Kimmel S, Woyshville M, et al. Clozapine for treatment-refractory mania. Am J of Psychiatry. 1996;153(6):759–764. PubMed

Sajatovic M, DiGiovanni S, Bastani B, Hattab H, Ramire L. Risperidone Therapy in Treatment Refractory Acute Bipolar and Schizoaffective Mania. Psychopharmacol Bull. 1999;32(1):55–61. PubMed

Green A, Tohen M, Patel J, et al. Clozapine in the Treatment of Refractory Psychotic Mania. Am J of Psychiatry. 2000;157(6):982–986. PubMed

Vieta E, Torrent C, Garcia-Ribas G, et al. Use of topiramate in treatment-resistant bipolar spectrum disorders. Journal of Clinical Psychopharmacology. 2002;22(4):431–435. PubMed

Chen J, Muzina D, Kemp D, et al. Safety and efficacy of olanzapine monotherapy in treatment-resistant bipolar mania: a 12-week open-label study. Hum Psychopharmacol. 2011;26(8):588–595. PubMed

Manhas RS, Mushtaq R, Tarfarosh SFA, et al. An Interventional Study on the Clinical Usefulness and Outcomes of Electroconvulsive Therapy in Medication-Resistant Mental Disorders. Cureus. 2016;8(10):e832. PubMed PMC

Suppes T, Webb A, Paul B, Carmody T, Kraemer H, Rush AJ. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. American journal of psychiatry. 1999;156(8):1164–1169. PubMed

Evins A, Demopulos C, Nierenberg A, Culhane M, Eisner L, Sachs G. A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania. Bipolar Disord. 2006;8(1):75–80. PubMed

Vik A, Ravindran A, Shiah I-S, Wong H, Walji N, Ram R, Yatham L. A double-blind, placebo controlled study of adjunctive calcitonin nasal spray in acute refractory mania. Bipolar Disord. 2013;15(4):359–364. PubMed

Bulut M, Çatı S, Güneş M, Kaya M, Kaplan, Özkan M. Evaluation of serum inflammatory markers in treatment-resistant manic patients and adequate responder manic patients. Psychiatry Res. 2019;272:73–79. PubMed

Gerner RH. Treatment of acute mania. Psychiatric Clinics of North America. 1993;16(3):443–460. PubMed

Tohen M, Gannon KS. Pharmacologic approaches for treatment-resistant mania. Psychiatric Annals. 1998;28(11):629–632.

Fountoulakis KN. Refractoriness in bipolar disorder: Definitions and evidence-based treatment. CNS Neuroscience & Therapeutics. 2012;18(3):227–237. PubMed PMC

Poon SH, Sim K, Sum MY, Kuswanto CN, Baldessarini RJ. Evidence-based options for treatment-resistant adult bipolar disorder patients. Bipolar Disorders. 2012;14(6):573–584. PubMed

Keck PE Jr., McElroy SL. Definition, evaluation, and management of treatment refractory mania. Psychopharmacology bulletin. 2001;35(4):130–148. PubMed

Gajwani. Treatment-refractory bipolar disorder: Classification to aid in clinical management. Expert Opinion on Pharmacotherapy. 2009;10(12):1907–1915. PubMed

Suzuki T, Remington G, Mulsant H, et al. Treatment resistant schizophrenia and response to antipsychotics: a review. Schizophr Res. 2011;133(1-3):54–62. PubMed

Howes, McCutcheon;, Agid;, Bartolomeis;, van Beveren NBMBMB RA; Buchanan RW; Carpenter WT; Castle DJ; Citrome L; Daskalakis ZJ; Davidson M; Drake RJ; Dursun S; Ebdrup BH; Elkis H; Falkai P; Fleischacker WW; Gadelha A; Gaughran F; Glenthøj BY; Graff-Guerrero A; Hallak JE; Honer WG; Kennedy J; Kinon BJ; Lawrie SM; Lee; J, Leweke FM; MacCabe JH; McNabb CB; Meltzer H; Möller H-J; Nakajima S; Pantelis C; Marques TR; Remington G; Rossell SL; Russell BR; Siu CO; Suzuki T; Sommer IE; Taylor D; Thomas N; Üçok A; Umbricht D; Walters JTR; Kane J; Correll CU. Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology. Am J of Psychiatry. 2017;174(3):216–229. PubMed PMC

Margoob, Chandel;, Mushtaq;, Mushtaq D. Treatment-Resistant Obsessive-Compulsive Disorder (OCD) – Current Understanding. In: IntechOpen, ed. Obsessive-Compulsive Disorder - The Old and the New Problems 2014.

Brown R, Taylor MJ, Geddes J. Aripiprazole alone or in combination for acute mania. Cochrane Database Syst Rev. 2013(12):Cd005000. PubMed PMC

Cipriani A, Rendell JM, Geddes JR. Haloperidol alone or in combination for acute mania. Cochrane Database Syst Rev. 2006(3):Cd004362. PubMed

Mohr P, Masopust J, Kopeček M. Dopamine Receptor Partial Agonists: Do They Differ in Their Clinical Efficacy? Front Psychiatry. 2021;12:781946. PubMed PMC